Your browser doesn't support javascript.
loading
Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3ß-Snail pathway.
Namba, T; Kodama, R; Moritomo, S; Hoshino, T; Mizushima, T.
Affiliation
  • Namba T; Science Research Center, Kochi University, Kochi 783-8505, Japan.
  • Kodama R; Science Research Center, Kochi University, Kochi 783-8505, Japan.
  • Moritomo S; Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan.
  • Hoshino T; Department of Analytical Chemistry, Faculty of Pharmacy, Keio University, Tokyo 105-8512, Japan.
  • Mizushima T; Department of Analytical Chemistry, Faculty of Pharmacy, Keio University, Tokyo 105-8512, Japan.
Cell Death Dis ; 6: e1795, 2015 Jun 25.
Article de En | MEDLINE | ID: mdl-26111057

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antiviraux / Tumeurs du pancréas / Zidovudine / Résistance aux médicaments antinéoplasiques / Désoxycytidine Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Cell Death Dis Année: 2015 Type de document: Article Pays d'affiliation: Japon

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antiviraux / Tumeurs du pancréas / Zidovudine / Résistance aux médicaments antinéoplasiques / Désoxycytidine Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Cell Death Dis Année: 2015 Type de document: Article Pays d'affiliation: Japon